GOTHENBURG, SWEDEN / ACCESS Newswire / February 20, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA) Gothenburg, Sweden, 20 ...

Multiple system atrophy (MSA) is a rare neurological disorder that leads to the progressive deterioration of nerve cells in ...

GOTHENBURG, SWEDEN / ACCESS Newswire / February 17, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)/ IRLAB Therapeutics AB , a company discovering and developing novel treatments for Parkinson's ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

GOTHENBURG, SWEDEN / ACCESS Newswire / February 17, 2025 / IRLAB Therapeutics (STO:IRLAB-A)(FRA:6IRA)/ IRLAB Therapeutics AB (Nasdaq Stockholm:IRLAB A), a company discovering and developing novel trea ...

Gene therapies have entered clinical trials for several neurological disorders, most notably Parkinson disease. A study in a nonhuman primate model of Parkinson disease has reported motor deficit ...

The progressive increments of the hormone induced an increase in manifestations of Parkinsonism: tremor appeared or became aggravated whereas muscular strength, posture, gait and associated ...

1Department of Oncology, Montefiore Einstein Comprehensive Cancer Center, Bronx, New York.

The FDA has approved Neurocrine Bioscience’s Ingrezza, the first ever licensed treatment for tardive dyskinesia or TD. The condition is characterised by uncontrollable movement of the body or ...

It causes uncontrollable, violent, jerky, muscle movements, called dyskinesias, in nearly every part of my body. These dyskinesias resemble the effects of illicit substances and can make people ...